ADI-PEG 20

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma MultiformeNCT04587830Polaris GroupPhase 2Active not recruiting2027-02-28Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.